MECHANISMS OF RESISTANCE ARTERY STRUCTURAL REMODELING IN HYPERTENSION
MECHANISMS OF RESISTANCE ARTERY STRUCTURAL REMODELING IN HYPERTENSION
批准号:
7959842
负责人:
KHALID MATROUGUI
金额:
$13.81万
依托单位国家:
美国
项目类别:
财政年份:
2009
资助国家:
美国
项目状态:
已结题
起止时间:
2009-07-01 至 2010-06-30
关键词:
ANG geneAdenovirusesAntioxidantsArteriesBiologyBlood VesselsCardiovascular DiseasesCenters of Research ExcellenceCollagen Type IComputer Retrieval of Information on Scientific Projects DatabaseDominant-Negative MutationDown-RegulationEpidemicFundingGrantHealthHypertensionI-kappa B ProteinsInfectionInstitutionIntegrin alphaVbeta3Integrin alphaVbeta3 inhibitionMechanicsMediatingMesenteryMitochondriaModelingMorbidity - disease rateMusNF-kappa BNFKB Activation PathwayOxidative StressPathway interactionsPrevalencePropertyRenal HypertensionResearchResearch PersonnelResistanceResourcesRisk FactorsRoleSmall Interfering RNASourceStructureTNFRSF5 geneTransforming Growth Factor betaUnited States National Institutes of Healthacetovanilloneblood pressure regulationhigh riskhuman TGFB1 proteinmitoquinonemortalityoverexpressionp65receptorresistance mechanism
中文摘要
点击翻译按钮获取中文摘要
英文摘要
This subproject is one of many research subprojects utilizing the
resources provided by a Center grant funded by NIH/NCRR. The subproject and
investigator (PI) may have received primary funding from another NIH source,
and thus could be represented in other CRISP entries. The institution listed is
for the Center, which is not necessarily the institution for the investigator.
Background and hypothesis:
Alteration of vascular structure has been largely accepted as a significant health threat and high risk factor in cardiovascular disease. Hypertension, the most important risk factor for cardiovascular disease, is at epidemic levels in the UNITED STATES being responsible for increased prevalence of vascular complications, and morbidity and mortality. Our central hypothesis is that elevated oxidative stress activates NFKB pathway leading to alpha-v-beta-3-integrin shedding and TGFbeta-1 expression and bio-activity increase, which induces structural wall remodeling responsible for altered mechanical properties of resistance artery from Ang-II-dependent hypertensive mice. We will use mesenteric resistance arteries (MRA) because they are good model reflecting changes in vessels, representative of microvessels and responsible for more than 30% blood pressure control.
We have two Specific Aims to accomplish our proposal:
Overall, our Specific Aim 1 is focused on the role of the enhanced oxidative stress-dependent NFKB pathway activation responsible for the increased collagen type 1 content, stiffness, and eutrophic remodeling induction of MRA from Ang-II-dependent hypertensive mice. To achieve this aim, we will determine if:
Subaim 1a: treatment of Ang-II-dependent hypertensive mice with lower oxidative stress "apocynin or mitoquinone (MitoQ: is a mitochondria-targeted antioxidant that selectively blocks mitochondrial oxidative stress)", and the use of mice that over-express mitochondrial MnSOD infused with Ang-II to reduce the increased NFKB pathway activation and translocation, alpha-v-beta-3-integrin shedding, TGFbeta-1 expression and bioactivity, eutrophic remodeling, collagen type 1 content, and stiffness of MRA from Ang-II-dependent hypertensive mice;
Subaim 1b: local down regulation of NFKB pathway by local infection of MRA from ANG II-dependent hypertensive mice with adenovirus-mediated IKB or p50/p65 NFKB subunits-siRNA delivery potentiates or reduces, respectively, the increased alpha-v-beta-3-integrin shedding, TGFbeta-1 expression, collagen type 1 content, stiffness and eutrophic remodeling induction;
Overall, our Specific Aim 2 is directed to determine the role of enhanced alpha-v-beta-3-integrin shedding and TGFbeta-1 expression on increased collagen type 1 content, stiffness, and eutrophic remodeling induction in MRA from Ang-II-dependent hypertensive mice. To accomplish this aim, we will ascertain if:
2a: local down regulation of alpha-v-beta-3-integrin by local infection of MRA from ANG II-dependent hypertensive mice with adenovirus-mediated alpha-v-beta-3-integrin-siRNA delivery and the use of pharmacological inhibition of alpha-v-beta-3-integrin reduce the increased TGF beta-1 bioactivity, collagen type 1 content, stiffness, and eutrophic remodeling induction of MRA from;
2b: local down regulation of TGFbeta-1 by local infection of MRA from ANG II-dependent hypertensive mice with adenovirus-mediated TGFbeta-1-siRNA delivery, and the use of mice overexpressing dominant negative TGFbeta-1 receptor infused with ANG II reverse the increased collagen type 1 content, stiffness, and eutrophic remodeling induction of MRA.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Interleukin 12 disruption provides beta cell and microvessel protection in type 2diabetes
-
批准号:10219830
-
项目类别:
-
资助金额:$44.92万
-
财政年份:2020
-
负责人:KHALID MATROUGUI
-
依托单位:
Stromal interaction molecule 1, immune cells, and vascular pathology in established hypertension
-
批准号:10206263
-
项目类别:
-
资助金额:$37.5万
-
财政年份:2020
-
负责人:KHALID MATROUGUI
-
依托单位:
Stromal interaction molecule 1, immune cells, and vascular pathology in established hypertension
-
批准号:10673211
-
项目类别:
-
资助金额:$37.5万
-
财政年份:2020
-
负责人:KHALID MATROUGUI
-
依托单位:
Stromal interaction molecule 1, immune cells, and vascular pathology in established hypertension
-
批准号:10455479
-
项目类别:
-
资助金额:$37.5万
-
财政年份:2020
-
负责人:KHALID MATROUGUI
-
依托单位:
Interleukin 12 disruption provides beta cell and microvessel protection in type 2diabetes
-
批准号:10650143
-
项目类别:
-
资助金额:$44.92万
-
财政年份:2020
-
负责人:KHALID MATROUGUI
-
依托单位:
Interleukin 12 disruption provides beta cell and microvessel protection in type 2diabetes
-
批准号:10444975
-
项目类别:
-
资助金额:$44.92万
-
财政年份:2020
-
负责人:KHALID MATROUGUI
-
依托单位:
Mechanisms of Coronary Arteriolar Dysfunction in Type 2 Diabetes
-
批准号:8383472
-
项目类别:
-
资助金额:$34.52万
-
财政年份:2010
-
负责人:KHALID MATROUGUI
-
依托单位:
Mechanisms of Coronary Arteriolar Dysfunction in Type 2 Diabetes
-
批准号:7792312
-
项目类别:
-
资助金额:$37.25万
-
财政年份:2010
-
负责人:KHALID MATROUGUI
-
依托单位:
Mechanisms of Coronary Arteriolar Dysfunction in Type 2 Diabetes
-
批准号:8013945
-
项目类别:
-
资助金额:$37.25万
-
财政年份:2010
-
负责人:KHALID MATROUGUI
-
依托单位:
Mechanisms of Coronary Arteriolar Dysfunction in Type 2 Diabetes
-
批准号:8611809
-
项目类别:
-
资助金额:$35.53万
-
财政年份:2010
-
负责人:KHALID MATROUGUI
-
依托单位:
MECHANISMS OF RESISTANCE ARTERY STRUCTURAL REMODELING IN HYPERTENSION
-
批准号:8167897
-
项目类别:
-
资助金额:$16.39万
-
财政年份:2010
-
负责人:KHALID MATROUGUI
-
依托单位:
Mechanisms of Coronary Arteriolar Dysfunction in Type 2 Diabetes
-
批准号:8197533
-
项目类别:
-
资助金额:$36.88万
-
财政年份:2010
-
负责人:KHALID MATROUGUI
-
依托单位:
MECHANISMS OF RESISTANCE ARTERY STRUCTURAL REMODELING IN HYPERTENSION
-
批准号:7725311
-
项目类别:
-
资助金额:$13.17万
-
财政年份:2008
-
负责人:KHALID MATROUGUI
-
依托单位:
海外基金